Dr. Reddy's Laboratories share news, announcements and annual reports
NSE: DRREDDYBSE: 500124Pharmaceuticals & BiotechnologyMid Cap
Dr. Reddy's Laboratories Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 1986 on BSE, May 2003 on NSE
Last close ₹1,352.00up ₹7.00 (0.52%)BSE ₹1,350.20
Share price at the NSE close on 30 Oct 2026. Previous close ₹1,345.00.
30 Oct: open ₹1,345.00, high ₹1,363.70, low ₹1,345.00
52-week range of traded prices to 30 Oct 2026
₹1,101.00Low, 23 Jul 2026₹1,414.90High, 29 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,12,849 Cr104th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 40.30
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.91
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.59%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.15
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 17,14,05957.9% delivered
Dr. Reddy's Laboratories share news and announcements
1,702 announcements, routine notices left out, newest first. Page 28 of 35.
Apr 2013
Mar 2013
Feb 2013
18 Feb · Corporate action
Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors has fixed February 22, 2013 as record date for the purpose of ascertaining the debenture holder's entitlement to receive the second year's interest, at the rate of 9.25% per annum, on Non-convertible Debentures (NCDs) of the Company due for payment on March 24, 2013. The said interest on NCDs will be credited/paid on March 24, 2013.14 Feb · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2012 as follows: Net Sales of Rs. 212460 lacs for the quarter ending on 31-DEC-2012 against Rs. 209011 lacs and Rs. 156680 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively. Net Profit / (Loss) of Rs. 34664 lacs for the quarter ending on 31-DEC-2012 against Rs. 36303 lacs and Rs. 10803 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively.
Jan 2013
18 Jan · Board meeting
Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2012.8 Jan · Business
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 2,480 equity shares of Rs. 5/- each of the Company, fully paid up, on January 07, 2013, to Employees on exercise of their Stock Options as per the following details : (a) 1,930 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (b) 550 equity shares of Rs.5/- each underlying 550 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
Dec 2012
Nov 2012
Oct 2012
30 Oct · Consolidated Result Updates - IFRS
30 Oct · Results
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2012 as follows: Net Sales of Rs. 204129 lacs for the quarter ending on 30-SEP-2012 against Rs. 174755 lacs and Rs. 161256 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively. Net Profit / (Loss) of Rs. 36303 lacs for the quarter ending on 30-SEP-2012 against Rs. 17766 lacs and Rs. 13850 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively.8 Oct · Board meeting
Inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2012.
Sep 2012
3 Sep · Business
Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 26,082 equity shares of Rs. 5/- each of the Company, fully paid up, on September 01, 2012, to Non-Executive Directors / Employees on exercise of their Stock Options as per the following details. (a) 12,470 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 13,612 equity shares of Rs.5/- each underlying 13,612 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
Aug 2012
Jul 2012
19 Jul · Consolidated Result Updates - IFRS